Interstitial laser therapy for breast cancer

NICE interventional procedures guidance [IPG89] Published date:

Register an interest in this interventional procedure

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on interstitial laser therapy for breast cancer.

The guidance was considered for reassessment in January 2011 and it was concluded that NICE will not be updating this guidance at this stage. However, if you believe there is new evidence which should warrant a review of our guidance, please contact us via the email address below.

  • Description

    Standard treatments for small breast cancers include lumpectomy or mastectomy (without preceding laser therapy), and minimally invasive techniques such as radiofrequency ablation or cryotherapy.

    Interstitial laser therapy is a minimally invasive technique for treating small breast cancers. After locating the tumour using stereotactic techniques or ultrasound, laser energy is delivered into the tumour via a needle probe. This causes the tumour to shrink. A surgeon may then remove the tumour, although sometimes surgery is not necessary.

  • OPCS4.6 Code(s)

    B40.1 Interstitial laser destruction of lesion of breast

    In addition an ICD-10 code from category C50.- Malignant neoplasm of breast or C79.8 Secondary malignant neoplasm of other specified sites is assigned.

    The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS.   The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.  www.connectingforhealth.co.uk/clinicalcoding

  • Get involved